Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Rev Esp Cardiol (Engl Ed). 2024 Jan;77(1):60-68. doi: 10.1016/j.rec.2023.05.001. Epub 2023 May 20.
Survivors of childhood cancer might be at increased risk of diastolic dysfunction at follow-up due to exposure to cardiotoxic treatment. Although assessment of diastolic function is challenging in this relatively young population, left atrial strain might provide a novel insight in this evaluation. Our aim was to examine diastolic function in a cohort of long-term survivors of childhood acute lymphoblastic leukemia by using left atrial strain and conventional echocardiographic parameters.
Long-term survivors who were diagnosed at a single center between 1985 and 2015 and a control group of healthy siblings were recruited. Conventional diastolic function parameters and atrial strain were compared, and the latter was measured during the 3 atrial phases: reservoir (PALS), conduit (LACS) and contraction (PACS). Inverse probability of treatment weighting was used to account for differences between the groups.
We analyzed 90 survivors (age, 24.6±9.7 years, time since diagnosis 18 [11-26] years) and 58 controls. PALS and LACS were significantly reduced compared with the control group: 46.4±11.2 vs 52.1±11.7; P=.003 and 32.5±8.8 vs 38.2±9.3; P=.003, respectively. Conventional diastolic parameters and PACS were similar between the groups. The reductions in PALS and LACS were associated with exposure to cardiotoxic treatment in age- and sex-adjusted analysis (≥ moderate risk, low risk, controls): 45.4±10.5, 49.5±12.9, 52.1±11.7; P=.003, and 31.7±9.0, 35.2±7.5, 38.2±9.3; P=.001, respectively.
Long-term childhood leukemia survivors showed a subtle impairment of diastolic function that was detected with atrial strain but not with conventional measurements. This impairment was more pronounced in those with higher exposure to cardiotoxic treatment.
由于儿童癌症幸存者接受了心脏毒性治疗,因此在随访期间可能会增加舒张功能障碍的风险。尽管在这个相对年轻的人群中评估舒张功能具有挑战性,但左心房应变可能会为评估提供新的见解。我们的目的是通过使用左心房应变和常规超声心动图参数来检查儿童急性淋巴细胞白血病长期幸存者的舒张功能。
在单个中心于 1985 年至 2015 年之间诊断出的长期幸存者和健康兄弟姐妹的对照组被招募。比较了常规舒张功能参数和心房应变,后者在 3 个心房阶段进行测量:储备(PALS),传导(LACS)和收缩(PACS)。使用逆概率治疗加权来解释组间差异。
我们分析了 90 名幸存者(年龄,24.6±9.7 岁,诊断后时间 18 [11-26]年)和 58 名对照组。与对照组相比,PALS 和 LACS 明显降低:46.4±11.2 对 52.1±11.7;P=0.003 和 32.5±8.8 对 38.2±9.3;P=0.003,分别。常规舒张参数和 PACS 在两组之间相似。在年龄和性别调整分析中,PALS 和 LACS 的降低与心脏毒性治疗的暴露有关(≥中度风险,低风险,对照组):45.4±10.5,49.5±12.9,52.1±11.7;P=0.003,和 31.7±9.0,35.2±7.5,38.2±9.3;P=0.001,分别。
长期儿童白血病幸存者的舒张功能存在轻微受损,心房应变可检测到,但常规测量无法检测到。在接受更高心脏毒性治疗的患者中,这种损害更为明显。